会务通学术会议服务平台

精确查询：

优化MUM1表位肽诱导特异性CTL抗Non-GCB型弥漫大B细胞淋巴瘤的实验研究

讲者：李荣

单位：长征医院

重型β地中海贫血患者糖尿病发生及相关因素研究

讲者：赖永榕

单位：广西医科大学第一附属医院

Risk Factors for Development of Ostenecrosis in Adult Acute Lymphoblastic Leukemia on Modified BFM 90 Protocol

讲者：Anusree Prabhakaran

单位：PGIMER, Chandigarh

$A Randomized, Multicenter, Open-Label, Phase 3 Study of the Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib Versus Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)$

A Randomized, Multicenter, Open-Label, Phase 3 Study of the Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib Versus Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

讲者：ShenMiao Yang

单位：北京大学人民医院

Chromosome copy number-neutral loss of heterozygosity/uniparental disomy (CN-LOH/UPD): a new category of genetic abnormalities in myelodysplastic syndromes

讲者：Shiyong Li

单位：Emory University Hospital

Long-Term Efficacy and Safety Analysis of Single-Agent Ibrutinib Therapy With 3 Years Follow-up in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL)

讲者：Jeffrey Jones

单位：The Ohio State University

Can Allo-HSCT Improve the Clinical Outcome for High-risk t(8;21)AML?

讲者：Yu Wang

单位：1

Long-term results of Rituximab-based immunochemotherapy for Previously Untreated Patients With chronic B lymphoproliferative diseases ——Report from a single center in China

讲者：Zengjun Li

单位：中国医学科学院北京协和医学院血液病医院血液学研究所

GVHD的标志物

讲者：任汉云

单位：北京大学第一医院

Laboratory Haematology Standardization: The International Council for Standardization in Haematology

讲者：Szu-Hee Lee

单位：TBD

共 288 条首页 | 上一页 | 14 15 16 17 18 19 20 21 22 | 下一页 | 尾页 10条/页转到第页